CEPI Collaborates with University of Hong Kong to Develop Vaccine for COVID-19

 CEPI Collaborates with University of Hong Kong to Develop Vaccine for COVID-19

CEPI Collaborates with University of Hong Kong to Develop Vaccine for COVID-19

Shots:

  • CEPI reports its seventh COVID-19 vaccine project and will invest $620,000 to HKU for the development of vaccine candidate against COVID-19, making the total investment of CEPI’s in COVID-19 vaccine R&D to $24.3M
  • CEPI will provide initial funding to HKU for preclinical testing of their vaccine candidate and will provide further funding for clinical testing, following the results of preclinical studies
  • The collaboration is a result of the global call for proposals, issued by CEPI in early Feb, which invited funding applications for proven vaccine technology which can be used to develop a vaccine against COVID-19

Click here ­to­ read full press release/ article | Ref: CEPI | Image: CEPI

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post